Francis Chou - Chou Associates Management 13F Activity & Position Changes (Q1 2017)
According to the SEC 13F filed on Aug 12, 2026, the Chou Associates Management portfolio showed several notable changes in holdings as of quarter-end Mar 31, 2017. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q1 2017, the filing reported:
New Buys - Teva Pharmaceutical Industries
Increases - SandRidge Energy, Inc.
Reductions - Nokia Corporation Sponsored
Complete Exits - Astrazeneca PLC
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.